Clinical Trial Update: Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

View source ↗

Summary

This trial update notes the completion of a study evaluating whether epidermal growth factor receptor (EGFR)–targeted therapy can improve survival in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ? | Status: COMPLETED